akela pharma

EUIPO EUIPO 2007 Registration expired

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark akela pharma was filed as Figurative mark on 06/29/2007 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/18/2008. The current status of the mark is "Registration expired".

Logodesign (Wiener Klassifikation)

#Tigers or other large felines #Animals of Series I stylized

Trademark Details Last update: May 15, 2024

Trademark form Figurative mark
File reference 006054126
Application date June 29, 2007
Publication date November 26, 2007
Entry date July 18, 2008
Expiration date June 29, 2017

Trademark owner

3333 Cote-Vertu Blvd., Suite 710
H4R 2N1 Saint-Laurent,
CA

Trademark representatives

2, place d' Estienne d'Orves 75009 Paris FR

goods and services

5 Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system; pharmaceutical preparations and substances for use in pain control and pain management, arthritis, anesthesia, asthma, oncology, urology, gynecology; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases and arthritis; pharmaceutical preparations and substances for the treatment and prevention of diabetes; pharmaceutical, veterinary and sanitary preparations and dietetic substances adapted for medical use, namely, psychotropic, cardiovascular agents, vasotherapeutics in the form of ampoule, tablets or liquid, anti-infective, antibiotics, chemotherapeutics, antiviral agents, hormones, metabolic agents in the form of caplets or liquid or particulate inhaleable formulation namely peptides, polypeptides, opiods, opiod derivatives, pain agents, amino acids, peptides, creatine, dextrose, vitamin C, antidiabetic drugs, agents for digestive disorders namely antiacids, anti-diarrhea and antiemetics in the form of liquid or caplets, antiallergic drugs, analgesics, spasmolytic drugs, narcotics, anesthetics, antiphlogistic, antirheumatic and anti asthmatic agents; dermatological preparations namely creams for the treatment of pain, acne, eczema, dry skin, psoriasis and other immune system controlling agents namely vaccines, drugs to treat osteoporosis, tumor therapeutics; biological products namely for pharmaceutical, clinical or medical laboratory use, namely biological reagents for diagnostic and scientific purposes, antiemetics, pain treatment drugs, vaccines, infusions of said drugs; plasters namely material plasters, adhesive plasters, mucosa plasters, drug bearing plasters and films, materials for dressings; material for stopping teeth: prepared and processed proteins and myco-proteins for human consumption; tissues and materials impregnated with pharmaceutical substances namely opiod bearing films; pharmaceutical and veterinary products in the form of caplets, liquid to be administrated by injection, liquid to be orally administrated for the prevention and treatment of obesity, smoking cessation, nephropathy, pulmonary embolism, atherothrombosis, asthma, hypertension, thrombosis, arrhythmia, angina, hypertension, heart failure, insomnia, epilepsy, schizophrenia, fever and pain; pharmaceutical preparations for the treatment of the central nervous system, namely, neurotic and psychosomatic disorder namely anxiety, depression, hysteria, stress, fears; prostatic hyperplasia, granuloma inguinale, bilharziasis, and other protozoal infections, namely babesios, coccidiosis, cryptosporidiosis, malaria, toxoplasmosis, trichomoniasis, trypanosomiasis
10 Inhalers and applicators for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system; inhalers and applicators for use in pain control, asthma treatment, arthritis, anesthesia, oncology, infection, inflammation, urology, gynecology, dental care, surgery and radiology; inhalers and applicators for the treatment and prevention of diabetes; apparatus and instruments for use in pain control and pain management, arthritis, asthma, anesthesia, oncology, infection, inflammation, urology, gynecology, dental care, surgery respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system and radiology; apparatus and instruments for the treatment and prevention of diabetes; medical devices, namely, medical apparatus namely a unit for aerosol drug delivery to the deep lung of drugs as fine, dry particles; surgical, medical, dental and veterinary apparatus and instruments, namely, aerosol dispensers for medical purposes, injectors for medical purposes, pumps for medical purposes
42 Chemical analysis and research; computer programming; industrial research; technological research; design and testing of new products; conducting agricultural surveys, testing of materials; testing of plant; testing of products
44 Diagnostic testing and analysis in the field of pharmaceuticals and healthcare; laboratories for testing materials and research in the field of pharmaceuticals and healthcare; advisory services relating to healthcare; consultancy services relating to healthcare; pharmaceutical and healthcare services for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system, pain management, pharmacy advice; medical counseling; pharmaceutical and healthcare services in the field of pain control and management, arthritis, anesthesia, asthma, oncology, infection, inflammation, urology, cancer, pain, gynecology; pharmaceutical and healthcare services for the treatment and prevention of diabetes; technical consulting and research services; namely, providing consultation, research and development services relating to drug performance and/or drug delivery performance to others in the biotechnical, biomedical and pharmaceutical fields

Trademark history

Date Document number Area Entry
May 3, 2018 Extension, Trade mark expired
August 12, 2010 Change Representative, Published
July 21, 2008 RAW: Correction of errors - Absolute errors, Published

ID: 11006054126